All the news Showing 10 of 16 articles from: Deciding when and how to treat HCVGet an RSS feed of these articles Show All news infohep newsEditors' picks from other sources Hepatitis C treatment can be shortened in 50 percent of patients, study finds Eurekalert Inf Dis / 12 November 2018 BIDMC researchers develop decision-making tool to benefit patients with HCV Eurekalert Medicine & Health / 20 June 2018 Hepatitis C Guidance Underscores the Importance of Treating HCV Infection: Panel Recommends Direct-Acting Drugs for Nearly All Patients with Chronic Hepatitis C IDSA / 27 October 2015 Hepatitis C: 25 Years Old, and Fading Medscape / 17 June 2015 Is There Any Good Reason Left to Delay Hepatitis C Treatment? Poz / 17 April 2015 PCORI Board Approves Providing Up to $50 Million for Research on Hepatitis C Treatment Comparisons Patient Centered Outcomes Research Institute / 10 December 2014 Deferral of treatment in HCV patients: Risks and benefits Hepatitis B & C Public Policy Association / 17 February 2014 Express Scripts Pushes Price Competition for Gilead Drug Bloomberg / 11 December 2013 US docs hold back patients until new HCV drugs arrive Pharma Times / 06 November 2013 Studies: Current hepatitis C treatments can't be used by more than half of patients; others lose opportunity for treatment Henry Ford Health System press release / 01 November 2013 ← First12Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Hepatitis C Hepatitis D Hepatitis E Coronavirus NAFLD Treatment for hepatocellular carcinoma Transmission, epidemiology and prevention Health services, policy and advocacy Social issues Conference news Email bulletin archive